Concepedia

G. Rosenkranz

GR

Statistics

Publications

100

Citations

3K

H-Index

31

Active since

1948

Affiliations

Novartis (Switzerland)(Current)

Medical University of Vienna

G. Rosenkranz is an author at Novartis (Switzerland) specializing in life sciences, steroid biochemistry, and biochemistry.

ORCID

Publications per year

1948–2022

100

Publications

100

Steroids. LIV.<sup>1</sup> Synthesis of 19-Nov-17α-ethynyltestosterone and 19-Nor-17α-methyltestosterone<sup>2</sup>

Carl Djerassi, L. Miramontes, G. Rosenkranz et al. · Journal of the American Chemical Society · 1954 · 173 citations

, , +10

Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study

Donald B. Bailey, Elizabeth Berry‐Kravis, Anne Wheeler et al. · Journal of Neurodevelopmental Disorders · 2015 · 100 citations · Full text

, , +16

Steroids. IV.<sup>1a</sup> α-Iodoketones. A Method for the Conversion of Allosteroids into ▵<sup>4</sup>-3-Ketosteroids<sup>1b</sup>

G. Rosenkranz, O. Mancera, J. Gatica et al. · Journal of the American Chemical Society · 1950 · 88 citations

, , +9

Steroids. VII.<sup>1</sup> Contribution to the Bromination of ▵<sup>4</sup>-3-Ketosteroids and a New Partial Synthesis of the Natural Estrogens

Carl Djerassi, G. Rosenkranz, J. Romo et al. · Journal of the American Chemical Society · 1950 · 83 citations

, , +9

Estimands and Their Role in Clinical Trials

Mouna Akacha, Frank Bretz, David Ohlssen et al. · Statistics in Biopharmaceutical Research · 2017 · 80 citations

, , +11

1–5 of 100